Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 8

1.

Tumor vasculature is regulated by PHD2-mediated angiogenesis and bone marrow-derived cell recruitment.

Chan DA, Kawahara TL, Sutphin PD, Chang HY, Chi JT, Giaccia AJ.

Cancer Cell. 2009 Jun 2;15(6):527-38. doi: 10.1016/j.ccr.2009.04.010.

2.

PHD2 in tumour angiogenesis.

Chan DA, Giaccia AJ.

Br J Cancer. 2010 Jun 29;103(1):1-5. doi: 10.1038/sj.bjc.6605682. Epub 2010 May 11. Review.

3.

[Hypoxia-responsive factor PHD2 and angiogenic diseases].

Jia HZ, Kasim V, Xu ZL, Yang L, Wu SR.

Yao Xue Xue Bao. 2014 Feb;49(2):151-7. Review. Chinese.

PMID:
24761603
4.

Cancer-stromal cell interactions mediated by hypoxia-inducible factors promote angiogenesis, lymphangiogenesis, and metastasis.

Semenza GL.

Oncogene. 2013 Aug 29;32(35):4057-63. doi: 10.1038/onc.2012.578. Epub 2012 Dec 10. Review.

5.

From vessel sprouting to normalization: role of the prolyl hydroxylase domain protein/hypoxia-inducible factor oxygen-sensing machinery.

Coulon C, Georgiadou M, Roncal C, De Bock K, Langenberg T, Carmeliet P.

Arterioscler Thromb Vasc Biol. 2010 Dec;30(12):2331-6. doi: 10.1161/ATVBAHA.110.214106. Epub 2010 Oct 21. Review.

6.

Role of endothelial progenitors and other bone marrow-derived cells in the development of the tumor vasculature.

Ahn GO, Brown JM.

Angiogenesis. 2009;12(2):159-64. doi: 10.1007/s10456-009-9135-7. Epub 2009 Feb 17. Review.

7.

Mechanisms of vascularization in murine models of primary and metastatic tumor growth.

Bugyik E, Renyi-Vamos F, Szabo V, Dezso K, Ecker N, Rokusz A, Nagy P, Dome B, Paku S.

Chin J Cancer. 2016 Feb 12;35:19. doi: 10.1186/s40880-016-0083-5. Review.

8.

Hypoxia and inflammation.

Eltzschig HK, Carmeliet P.

N Engl J Med. 2011 Feb 17;364(7):656-65. doi: 10.1056/NEJMra0910283. Review. No abstract available.

Supplemental Content

Support Center